3 reasons to stick with your Sonic Healthcare Limited shares

Expanding international healthcare company has a good dividend yield and growth prospects in big overseas markets.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When there is some anxiety and uncertainty in the markets, investors begin looking at defensive stocks that may not be as volatile and could still offer good dividend income. Healthcare stocks are regularly popular for this.

One company, Sonic Healthcare Limited (ASX: SHL), may not be a household name, but probably many investors or family members have used its services. It provides medical imaging and diagnostic testing services like x-rays and MRIs that many people have to get when visiting doctors. There's a steady stream of business that is directly connected to healthcare provision. About half of its business comes from overseas in large markets like the US and Germany.

The stock is up about 19% in the past twelve months, easily beating the 3.8% gain of the S&P ASX All Ordinaries Index (ASX: ^AORD) over the same period.

It hit a high of $55.33 in late April and has pulled back to $53.80 now. Is there more for this stock? Here are three reasons the company should remain in your portfolio.

1) Dividend income

The stock has a decent 3.8% dividend yield that could help if the market continues to go sideways. Dividend payouts have been steady and trending up over the past five years. Earnings per share over the next several years are forecast to rise, so dividends could follow suit.

2) Business growth

In the first half, it saw a healthy 7% rise in revenue for Australian pathology. Its US business beat that with a 12% revenue rise. The company expects substantial profit margin and earnings growth will continue into FY 2015 in the US. Europe as a whole is showing gains as well. The company is on track for its full year guidance.

3) Improving technology and cost cutting

A new lab in Perth was completed to improve growth and two labs in Sydney and Brisbane will be getting world-leading Total Lab Automation systems to keep their technological edge over competitors. Also, the US business has begun a cost-cutting initiative to further drive margins.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »